Organon OGN Other Women's Health — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organon's other women's health — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organon's other women's health — revenue?
- Organon (OGN) reported other women's health — revenue of $46M in Q1 2026.
- How has Organon's other women's health — revenue changed year-over-year?
- Organon's other women's health — revenue increased by 7.0% year-over-year, from $43M to $46M.
- What is the long-term trend for Organon's other women's health — revenue?
- Over 4 years (2021 to 2025), Organon's other women's health — revenue has grown at a -4.2% compound annual growth rate (CAGR), from $207M to $174M.
- What does other women's health — revenue mean?
- This metric represents the total net sales generated from the company's portfolio of women's health products that fall outside of its primary or core therapeutic focus areas. It serves as an indicator of the commercial performance and market demand for secondary reproductive and gynecological health offerings. Monitoring these revenues helps investors assess the contribution of niche or legacy women's health assets to the overall segment's top-line growth.